News25/Ratings0
Latest news
25 items- PRIssuer Direct Announces New Board of Directors to Support Next Chapter of GrowthRALEIGH, NC / ACCESSWIRE / July 1, 2024 / Issuer Direct Corporation (NYSE:ISDR), an industry-leading communications company, today announced it has appointed Wes Pollard and Joe Staples as new independent members of its Board of Directors."We are excited to welcome Wes and Joe to the Issuer Direct Board of Directors," said CEO Brian Balbirnie. "We believe their respective skillsets are an ideal fit for us as we pursue our strategic vision to be a leading provider of media and communications software to the PR (Public Relations) and IR (Investor Relations) industry. We are confident they will be valuable additions to our company as we continue to optimize our business and work to maximize val
- NEWSCathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On FridayCathie Wood’s Ark Investment Management on Friday bought 26,126 shares — estimated to be worth $163,026 — in Quantum-Si Inc (NASDAQ:QSI). Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date. Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund Ark Genomic Revolution ETF (BATS:ARKG). ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si ahead of Friday’s trade. The company went public earlier this year in a SPAC merger with HighCape Capital Acquisition Corp (NASDAQ:CAPA). Quantum-Si created the first next-gen protein sequencing pl
- PRQuantum-Si Announces Expansion of Early Access Program for the Platinum™ Single Molecule Protein Sequencing PlatformQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a life science tools company commercializing a unique protein sequencing platform, announced today that they have expanded their Platinum early access program to ten sites, with participation from leading academic centers and key industry partners. The early access program introduces the Platinum single molecule sequencing system to key opinion leaders across the globe, for both expansion and development of applications and workflows. "The Company is experiencing tremendous momentum and demand for participation in our early access program to analyze previously unapproachable levels of biological understanding of t
- PRQuantum-Si Incorporated to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare ConferenceQuantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si" or the "Company"), a company pioneering next-generation semiconductor chip-based proteomics, today announced its participation in the Cantor Fitzgerald Virtual Global Healthcare Conference which takes place September 27-30, 2021. John Stark, Quantum-Si's Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will participate in a virtual fireside chat on Wednesday, September 29, at 1:20 – 1:50 pm EDT. Please visit the Investor Relations section of the Quantum-Si website here to view the Company's most recent corporate presentation. About Quantum-Si Incorporated Founded by Dr. Jonathan Rothberg in 2013, Quantum-Si is focus
- PRQuantum-Si Reports Second Quarter 2021 Financial ResultsQuantum-Si Solidifies Financial Strength and Continues Systematic Commercialization Strategy Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si" or the "Company"), a company pioneering next-generation semiconductor chip-based proteomics, today announced financial results for the quarter ended June 30, 2021 and provided a business update. John Stark, Quantum-Si's Chief Executive Officer, and Claudia Drayton, Quantum-Si's Chief Financial Officer, will host a call today at 4:30 pm EDT to review the Company's results. Recent Highlights: Completed the business combination with HighCape Capital Acquisition Corp. ("HighCape"), adding over $511 million in cash to the balance sheet. Successfull
- PRQuantum-Si to Report Second Quarter 2021 Financial Results on August 16, 2021Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, today announced that it has rescheduled its conference call to report second quarter 2021 financial results to August 16, 2021, after market close. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET on August 16, 2021, to discuss second quarter 2021 financial results and provide a business update. The conference call will be broadcast live in listen-only mode via a webcast on Quantum-Si's Investor Relations website at Events & Presentations. Individuals interested in listening to the conference call on y
- SECHighCape Capital Acquisition Corp. filed SEC Form 8-K: Leadership Update8-K - Quantum-Si Inc (0001816431) (Filer)
- SECSEC Form S-1 filed by HighCape Capital Acquisition Corp.S-1 - Quantum-Si Inc (0001816431) (Filer)
- SECHighCape Capital Acquisition Corp. filed SEC Form 8-K: Leadership Update8-K - Quantum-Si Inc (0001816431) (Filer)
- SECHighCape Capital Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Quantum-Si Inc (0001816431) (Filer)
- PRQuantum-Si Signs Lease for Product Development and Operations Facility in San Diego Biotechnology HubQuantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today that it has entered into a lease agreement with Phase 3 Real Estate Partners, Inc. to develop a 25,586-square-foot product development and operations facility in San Diego, CA. The new facility, located in Sorrento Mesa, is being designed to scale production and expand research and development efforts. We expect this site will play a vital role in expanding the company's recruitment efforts within our product development team as the company prepares for commercial readiness. The location was specifically selected due to its vast network of talent to support research and develo
- 13D/GSEC Form SC 13D filed by HighCape Capital Acquisition Corp.SC 13D - Quantum-Si Inc (0001816431) (Subject)
- 13D/GSEC Form SC 13D filed by HighCape Capital Acquisition Corp.SC 13D - Quantum-Si Inc (0001816431) (Subject)
- INSIDERSEC Form 4: RAKIN KEVIN was granted 1,921,512 units of Class A Common Stock4 - Quantum-Si Inc (0001816431) (Issuer)
- SECHighCape Capital Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Changes in Registrant’s Certifying Accountant, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Change in Shell Company Status8-K - Quantum-Si Inc (0001816431) (Filer)
- SECHighCape Capital Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Quantum-Si Inc (0001816431) (Filer)
- INSIDERSEC Form 4: ROTHBERG JONATHAN M was granted 17,213,479 units of Class A Common Stock and was granted 19,937,500 units of Class B Common Stock4 - Quantum-Si Inc (0001816431) (Issuer)
- INSIDERSEC Form 4: Makes Brigid was granted 20,512 units of Class A Common Stock4 - Quantum-Si Inc (0001816431) (Issuer)
- INSIDERSEC Form 4: Tananbaum James B. was granted 8,424,317 units of Class A Common Stock4 - Quantum-Si Inc (0001816431) (Issuer)
- INSIDERSEC Form 4: Mina Michael was granted 20,512 units of Class A Common Stock4 - Quantum-Si Inc (0001816431) (Issuer)
- INSIDERSEC Form 4: Fattori Ruth A was granted 170,512 units of Class A Common Stock4 - Quantum-Si Inc (0001816431) (Issuer)
- INSIDERSEC Form 4: DEKKERS MARIJN E was granted 670,512 units of Class A Common Stock4 - Quantum-Si Inc (0001816431) (Issuer)
- INSIDERSEC Form 4: LaPointe Christian was granted 220,346 units of Class A Common Stock4 - Quantum-Si Inc (0001816431) (Issuer)
- INSIDERSEC Form 4: Dyer Matthew was granted 341,493 units of Class A Common Stock4 - Quantum-Si Inc (0001816431) (Issuer)
- INSIDERSEC Form 4: MCKENNA MICHAEL P was granted 877,250 units of Class A Common Stock4 - Quantum-Si Inc (0001816431) (Issuer)
CAPA FAQ
5 questionsWhere does CAPA stock trade?
HighCape Capital Acquisition Corp. (CAPA) is listed on NASDAQ.What sector and industry is CAPA in?
HighCape Capital Acquisition Corp. operates in the Finance sector, Business Services industry.When did HighCape Capital Acquisition Corp. go public?
HighCape Capital Acquisition Corp. (CAPA) completed its IPO in 2020.What companies are similar to CAPA?
Notable peers in the same industry include FLT (FleetCor Technologies Inc.), NVEI (Nuvei Corporation Subordinate Voting Shares), NLSN (Nielsen N.V.), STMP (Stamps.com Inc.), ENV (Envestnet Inc). Compare CAPA side-by-side with any of them on Quantisnow.How can I track CAPA on Quantisnow?
Quantisnow aggregates HighCape Capital Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CAPA to receive live email and push alerts on every new disclosure.